Skip to content
Baret News – Lifestyle
Author:
Keenova Therapeutics
Keenova Announces Two New TERLIVAZ® (terlipressin) Analyses at The Liver Meeting®
November 5, 2026
Keenova Therapeutics to Report Third Quarter 2026 Financial Results on November 10, 2026
November 2, 2026
Keenova Presents New TERLIVAZ® (terlipressin) Data Analyses at Kidney Week 2026
October 21, 2026
Keenova Presents a New TERLIVAZ® (terlipressin) Exploratory Analysis at American College of Gastroenterology Annual Meeting
October 12, 2026
Keenova Marks the 2nd Annual National Hand Health Month with New Dupuytren’s Contracture Mixed Reality Experience and Awareness Initiatives
September 1, 2026
Keenova Advances Podiatry Pipeline with First Patient Dosed in Phase 3 Trial of XIAFLEX® (collagenase clostridium histolyticum) for Hammer Toe
August 20, 2026
Keenova Reports Second Quarter 2026 Financial Results
August 11, 2026
Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology
August 4, 2026
Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026
July 30, 2026
Keenova Announces Publication of New Acthar® Gel (repository corticotropin injection) Manuscript in the Journal of Comparative Effectiveness Research
July 13, 2026
1
2
Next Page
→